| 注册
首页|期刊导航|中国药业|地佐辛注射液治疗癌性疼痛的系统评价

地佐辛注射液治疗癌性疼痛的系统评价

胡正波 卢海波 陈路佳 胡文利 唐榕 向帆

中国药业Issue(17):9-10,11,3.
中国药业Issue(17):9-10,11,3.

地佐辛注射液治疗癌性疼痛的系统评价

Meta-Analysis of Dezocine Injection in The Treatment of Cancer Pain

胡正波 1卢海波 1陈路佳 1胡文利 1唐榕 1向帆1

作者信息

  • 1. 中国人民解放军第452医院,四川 成都 610021
  • 折叠

摘要

Abstract

Objective To evaluate the efficacy and safety of Dezocine Injection in the treatment of Chinese with cancer Pain. Methods By Retrieving from CNKI,VIP and Wanfang database,according to include and exclude criterion,RCT about Dezocine injection in treat-ment of cancer Pain were collected. Meta-analysis was carried out. Results 7 RCT were included,involving 447 Patients in to-tal. Meta-analysis indicated that there was no statistical significance in effective rate [ RR=1. 00,95% CI ( 0. 94,1. 07 ) ,P=0. 90 ] ,the imProvement rate of quality of life [ MD= -0. 60,95%CI ( -1. 61,0. 41 ) ,P=0. 24 ] between the exPerimental grouP and control grouP. The adverse reaction in the treatment grouP was significantly lower than in the control grouP[ OR=0. 35,95% CI(0. 22,0. 58),P<0. 05]. Conclusion Dezocine injection is effective as MorPhine injection in the treatment of cancer Pain with less adverse reaction,but it also need high-quality large-scale long-term studies for further validation.

关键词

地佐辛注射液/癌痛/Meta分析

Key words

dezocine injection/cancer Pain/Meta-Analysis

分类

医药卫生

引用本文复制引用

胡正波,卢海波,陈路佳,胡文利,唐榕,向帆..地佐辛注射液治疗癌性疼痛的系统评价[J].中国药业,2015,(17):9-10,11,3.

中国药业

1006-4931

访问量0
|
下载量0
段落导航相关论文